Picard Medical, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -1.4% | +7.7% | -20.3% | +3.3% | +2.4% | -2.3% | +0.8% | +2.4% | +4.6% | +1.5% | – | |
| – | – | – | +525.8% | +124.2% | -48.0% | -37.6% | +29.8% | +11.5% | +10.8% | -27.0% | +736.4% | – | |
| – | – | -120.1% | – | – | -18.7% | -4.0% | +15.2% | -487.5% | – | – | +500.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +197.0% | +1,074.7% | – | – | – | – | |
| – | – | – | – | – | +27.9% | -27.8% | -44.6% | -642.2% | – | -152.1% | -75.8% | – | |
| – | +74.8% | -31.9% | +44.3% | -28.4% | +27.9% | -12.3% | -19.6% | +292.8% | +45.5% | -157.8% | – | – | |
| – | – | -32.0% | -300.0% | – | – | +557.8% | -147.0% | – | +259.5% | -231.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.